CWA
DGX icon

Clearview Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Clearview Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13
Closed -$1.83K – 234
2023
Q2 		$1.83K Buy
+13
New +$1.79K ﹤0.01% 540

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clearview Wealth Advisors's DGX Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 13 shares — an estimated $1.83K sold.

Clearview Wealth Advisors first reported a position in DGX in Q2 2023 and held it in 1 quarter. The position peaked at $1.83K in Q2 2023. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Clearview Wealth Advisors reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Clearview Wealth Advisors sold 13 Quest Diagnostics shares in Q3 2023, an estimated $1.83K.
  • Clearview Wealth Advisors first reported a position in Quest Diagnostics in Q2 2023 and held it in 1 quarter.
  • Clearview Wealth Advisors's Quest Diagnostics position peaked at $1.83K in Q2 2023.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.